Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07030348

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Sponsor: Do Hyun Park

View on ClinicalTrials.gov

Summary

Purpose Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, and only 10 15% of all pancreatic cancer patients are operable or borderline operable. Therefore, there is an unmet need for early diagnosis of pancreatic cancer; however, biomarkers related to this are not well understood. This study aims to identify biomarkers for the early diagnosis of pancreatic cancer through duodenal pancreatic juice, which can be easily obtained through an endoscopy.

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

OBSERVATIONAL

Enrollment

263

Start Date

2024-01-02

Completion Date

2026-12-31

Last Updated

2025-06-22

Healthy Volunteers

Yes

Locations (3)

University of Colorado Hospital

Aurora, Colorado, United States

Cleveland Clinic

Cleveland, Ohio, United States

Asan Medical Center

Seoul, South Korea